Humanwell Healthcare (Group) Co.,Ltd.

600079

CNE000000QW6

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
20.75 ^CNY	+1.97%		+4.75%	-16.53%

Mar. 29	Humanwell Healthcare's Profit Drops, Operating Income Climbs in 2023	MT
Mar. 28	Humanwell Healthcare Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Humanwell Healthcare Co.,Ltd.(XSSC:600079) added to S&P Global BMI Index

September 21, 2020 at 12:00 am EDT

Humanwell Healthcare (Group) Co.,Ltd.(XSSC:600079) added to S&P Global BMI Index

Latest news about Humanwell Healthcare (Group) Co.,Ltd.

Humanwell Healthcare's Profit Drops, Operating Income Climbs in 2023	Mar. 29	MT
Humanwell Healthcare Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
China Approves Sale of Humanwell Healthcare Unit's Prostate Cancer Treatment	Mar. 06	MT
Humanwell Healthcare's Subsidiary Gets Nod to Register Idecalcidol Soft Capsules	Mar. 05	MT
Production Line of Humanwell Healthcare's Unit Passes UK Drug Regulator's Inspection	Feb. 27	MT
Humanwell Healthcare Co.,Ltd. completed the acquisition of essential business operations of PAION AG and PAION Deutschland GmbH.	Feb. 22	CI
Humanwell Healthcare's Subsidiary Gets Nod to Register Anesthesia Drug	Feb. 20	MT
Humanwell Healthcare's Unit Enters Phase II Trial of Gout Drug	Feb. 06	MT
Humanwell Unit Gets China Registration Certificate for Drug to Prevent Renal Allograft Rejection	Jan. 24	MT
Humanwell Healthcare Gets Registration Approval for Pain Medication	Jan. 05	MT
Humanwell Healthcare Co.,Ltd. signed an agreement essential business operations of PAION AG and PAION Deutschland GmbH.	Dec. 21	CI
Humanwell Healthcare's Unit Gets Nod for Registration of Acetaminophen Mannitol Injection	Dec. 20	MT
Humanwell Healthcare's Unit to Trial Naltrexone Bromide Tablets	Dec. 15	MT
Humanwell Healthcare Registers Anesthesia Drug	Nov. 08	MT
Humanwell Healthcare Registers Blood Clot Drug	Nov. 02	MT
Humanwell Healthcare Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Humanwell Healthcare's Unit Gets Nod to Trial HZ-J001 Cream	23-10-20	MT
Humanwell Healthcare Completes Transfer of Huatai Insurance Stake	23-10-11	MT
Humanwell Healthcare's Unit Gets FDA's Tentative Approval for Gabapentin Tablets	23-10-10	MT
Humanwell Healthcare’s Prostate Cancer Drug Secures Tentative US FDA Nod	23-09-29	MT
Humanwell Healthcare Unit Gets Registration Certificate for Azithromycin Dry Suspension	23-09-26	MT
Humanwell Healthcare's Unit Gets Nod to Trial HWH486 Capsules	23-09-25	MT
Humanwell Healthcare Registers Treatment Against Lung Diseases	23-09-19	MT
Humanwell Healthcare Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Humanwell Healthcare’s Controlling Shareholder Faces Regulatory Probe	23-08-09	MT

Chart Humanwell Healthcare (Group) Co.,Ltd.

Duration

Period

Chart Humanwell Healthcare (Group) Co.,Ltd.

More charts

Humanwell Healthcare (Group) Co., Ltd is a China-based company principally engaged in research and development, manufacture and distribution of medical and pharmaceutical products. The Companyâs products are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines and others. The Company also provides medical instruments. The Company distributes its products in both domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-04-29 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Humanwell Healthcare (Group) Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

20.75

Average target price

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
HUMANWELL HEALTHCARE (GROUP) CO.,LTD.	-16.53%	4.52B
NOVO NORDISK A/S	+24.17%	562B
JOHNSON & JOHNSON	-6.33%	358B
MERCK & CO., INC.	+19.90%	322B
ABBVIE INC.	+7.95%	297B
ASTRAZENECA PLC	+13.45%	219B
NOVARTIS AG	+6.04%	199B
ROCHE HOLDING AG	-10.51%	196B
PFIZER, INC.	-12.26%	149B
AMGEN INC.	-6.47%	146B

Other Pharmaceuticals

Humanwell Healthcare (Group) Co.,Ltd.

Equities

600079

CNE000000QW6

Pharmaceuticals

Humanwell Healthcare Co.,Ltd.(XSSC:600079) added to S&P Global BMI Index

Latest news about Humanwell Healthcare (Group) Co.,Ltd.

Chart Humanwell Healthcare (Group) Co.,Ltd.

Company Profile

Income Statement Evolution

Ratings for Humanwell Healthcare (Group) Co.,Ltd.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals